AI assistant
Sending…
ACHIEVE LIFE SCIENCES, INC. — Director's Dealing 2023
Jun 9, 2023
33882_dirs_2023-06-09_ee1cd798-dbac-45e5-88d9-e35129700a29.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ACHIEVE LIFE SCIENCES, INC. (ACHV)
CIK: 0000949858
Period of Report: 2023-03-29
Reporting Person: Sellig Thomas (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-03-29 | Stock Option (right to buy) | $5.97 | A | 23250 | Acquired | 2033-03-29 | Common Stock (23250) | Direct |
Footnotes
F1: These options were granted on March 29, 2023 (the "Grant Date") pursuant to the 2023 Non-Employee Director Equity Incentive Plan (the "Plan"), subject to the Plans approval by the Issuers stockholders. The Plan was approved by the Issuers stockholders at the Issuers 2023 Annual Meeting of Stockholders on June 7, 2023. These options will vest on the one month anniversary of the Grant Date and thereafter in monthly installments over 36 months.
More from ACHIEVE LIFE SCIENCES, INC.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Regulatory Filings
2026
Apr 16
Annual Report
2026
Mar 24
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Jan 30
Director's Dealing
2026
Jan 30
Director's Dealing
2026
Jan 30
Director's Dealing
2026
Jan 30
Director's Dealing
2026
Jan 30